210 related articles for article (PubMed ID: 12737325)
41. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
Båve U; Nordmark G; Lövgren T; Rönnelid J; Cajander S; Eloranta ML; Alm GV; Rönnblom L
Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
[TBL] [Abstract][Full Text] [Related]
42. Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB autoantigens.
Blann AD; Wainwright AC; Emery P
Ann Rheum Dis; 1992 Mar; 51(3):389-90. PubMed ID: 1575588
[TBL] [Abstract][Full Text] [Related]
43. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
Suresh L; Malyavantham K; Shen L; Ambrus JL
BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
[TBL] [Abstract][Full Text] [Related]
44. LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patients.
Tanaka T; Warner BM; Odani T; Ji Y; Mo YQ; Nakamura H; Jang SI; Yin H; Michael DG; Hirata N; Suizu F; Ishigaki S; Oliveira FR; Motta ACF; Ribeiro-Silva A; Rocha EM; Atsumi T; Noguchi M; Chiorini JA
Sci Rep; 2020 Sep; 10(1):15169. PubMed ID: 32939030
[TBL] [Abstract][Full Text] [Related]
45. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
[TBL] [Abstract][Full Text] [Related]
46. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
[TBL] [Abstract][Full Text] [Related]
47. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis.
Gordon TP; Bolstad AI; Rischmueller M; Jonsson R; Waterman SA
Autoimmunity; 2001; 34(2):123-32. PubMed ID: 11905842
[TBL] [Abstract][Full Text] [Related]
48. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis.
Javed A; Balabanov R; Arnason BG; Kelly TJ; Sweiss NJ; Pytel P; Walsh R; Blair EA; Stemer A; Lazzaro M; Reder AT
Mult Scler; 2008 Jul; 14(6):809-14. PubMed ID: 18573828
[TBL] [Abstract][Full Text] [Related]
49. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.
Shao H; Wu Y; Tao X; Liu Q; Ran C; Jin L; Tao J
Clin Exp Med; 2024 May; 24(1):96. PubMed ID: 38717644
[TBL] [Abstract][Full Text] [Related]
50. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
[TBL] [Abstract][Full Text] [Related]
51. Anti-salivary gland protein 1 antibodies in two patients with Sjogren's syndrome: two case reports.
Vishwanath S; Shen L; Suresh L; Ambrus JL
J Med Case Rep; 2014 May; 8():145. PubMed ID: 24885364
[TBL] [Abstract][Full Text] [Related]
52. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
[TBL] [Abstract][Full Text] [Related]
53. Inflammatory Stratification in Primary Sjögren's Syndrome Reveals Novel Immune Cell Alterations in Patients' Minor Salivary Glands.
Bharaj TK; Aqrawi LA; Fromreide S; Jonsson R; Brun JG; Appel S; Skarstein K
Front Immunol; 2021; 12():701581. PubMed ID: 34322130
[TBL] [Abstract][Full Text] [Related]
54. Primary Sjögren's syndrome (pSS): subjective symptoms and salivary findings.
Pedersen AM; Reibel J; Nauntofte B
J Oral Pathol Med; 1999 Aug; 28(7):303-11. PubMed ID: 10432196
[TBL] [Abstract][Full Text] [Related]
55. Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants.
Routsias JG; Touloupi E; Dotsika E; Moulia A; Tsikaris V; Sakarellos C; Sakarellos-Daitsiotis M; Moutsopoulos HM; Tzioufas AG
Mol Med; 2002 Jun; 8(6):293-305. PubMed ID: 12428060
[TBL] [Abstract][Full Text] [Related]
56. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
Miyawaki S
Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
[TBL] [Abstract][Full Text] [Related]
57. A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms.
Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
J Autoimmun; 2014 Jun; 51():67-74. PubMed ID: 24333103
[TBL] [Abstract][Full Text] [Related]
58. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
59. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
Scofield RH; Asfa S; Obeso D; Jonsson R; Kurien BT
J Immunol; 2005 Dec; 175(12):8409-14. PubMed ID: 16339583
[TBL] [Abstract][Full Text] [Related]
60. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome.
Reksten TR; Jonsson MV; Szyszko EA; Brun JG; Jonsson R; Brokstad KA
Rheumatology (Oxford); 2009 Sep; 48(9):1102-6. PubMed ID: 19574472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
